Bioinformatics to analyze the differentially expressed genes in different degrees of Alzheimer’s disease and their roles in progress of the disease
Authors:
- 5 February 2024
- journal article
- research article
- Published by Springer Nature in Journal of Applied Genetics
- Vol. 66 (1) , 73-85
Abstract
Employing bioinformatics approaches, this investigation pinpointed pivotal differentially expressed genes (DEGs) across the spectrum of Alzheimer’s disease (AD), from incipient to severe stages, using the GSE28146 dataset from the GEO repository. Analytical methods included DEG identification via the limma package in R, coupled with GO and KEGG pathway analyses through clusterProfiler, to discern biological processes and pathway involvements. Key findings spotlighted the roles of proteasome subunits PSMB4, PSMB8, PSMC4, and PSMD6 in the early stage, ribosomal proteins RPS3 and RPL11 during moderate AD, and mitochondrial components COX5B, COX6B2, and COX7A2 in severe AD, underscoring their importance in the disease’s pathogenesis. Conclusively, these results not only delineate the dynamic genetic shifts accompanying AD progression but also propose critical biomarkers for potential therapeutic targeting, offering a consolidated basis for future AD research and treatment development. This offered a novel idea for analyzing the pathogenesis and development of AD and investigation of targeted drugs.Keywords
This publication has 17 references indexed in Scilit:
- Disrupted Place Cell Remapping and Impaired Grid Cells in a Knockin Model of Alzheimer's DiseaseNeuron, 2020
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activationNature Medicine, 2020
- Transcranial Pulse Stimulation with Ultrasound in Alzheimer's Disease—A New Navigated Focal Brain TherapyAdvanced Science, 2019
- When Does Alzheimer′s Disease Really Start? The Role of BiomarkersInternational Journal of Molecular Sciences, 2019
- Antibiotics, gut microbiota, and Alzheimer’s diseaseJournal of Neuroinflammation, 2019
- The Alzheimer’s Disease Clinical SpectrumMedical Clinics of North America, 2019
- Network Medicine for Alzheimer’s Disease and Traditional Chinese MedicineMolecules, 2018
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and TreatmentJournal of Alzheimer’s Disease, 2017
- Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunitiesExpert Review of Molecular Diagnostics, 2014
- Alzheimer's disease - input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trialTrials, 2011